Besides, this new classification divided GBM into three classes: GBM IDH wild-type (about 90% of all cases), GBM IDH-mutant (about 10% of all cases), and GBM NOS (not otherwise specified) when IDH evaluation cannot be performed [15]. The gene discussed is IDH1; the disease is glioblastoma.